SCHEMBL5681122

SCHEMBL5681122

Cc1cc(Cl)cc2nc(N)[nH]c12

nearest known ligand 0.47

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
FABP6 P51161 1/20 0.47
HTR3E A5X5Y0 1/20 0.44
HTR3B O95264 1/20 0.44
HTR3A P46098 1/20 0.44
BACE1 P56817 1/20 0.44
HTR3D Q70Z44 1/20 0.44
HTR3C Q8WXA8 1/20 0.44
TYMS P04818 8/20 0.42
SLC9A1 P19634 1/20 0.38
CYP1A2 P05177 1/20 0.36
HRH4 Q9H3N8 2/20 0.35
NR4A2 P43354 1/20 0.35
ATP4A P20648 1/20 0.34
ATP4B P51164 1/20 0.34
ALDH1A1 P00352 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5924316 0.81 FABP6 (0.50) FABP6HTR3EHTR3BHTR3ABACE1
SCHEMBL6621861 0.81 FABP6 (0.50) FABP6HTR3EHTR3BHTR3ABACE1
SCHEMBL5924445 0.81 HTR3E (0.47) FABP6HTR3EHTR3BHTR3ABACE1
SCHEMBL13544179 0.81 ALDH1A1 (0.47) TYMSCYP1A2HRH4ALDH1A1
SCHEMBL6856404 0.78 FABP6 (0.47) FABP6HTR3EHTR3BHTR3ABACE1
SCHEMBL2107199 0.78 CYP1A2 (0.36) CYP1A2HRH4ALDH1A1
SCHEMBL13542764 0.75 KDM4E (0.40) CYP1A2HRH4ALDH1A1
SCHEMBL5772789 0.75 CYP1A2 (0.35) CYP1A2HRH4ALDH1A1
SCHEMBL14468044 0.75 FABP6 (0.44) FABP6BACE1TYMSATP4AATP4B
SCHEMBL11669082 0.74 FABP6 (0.43) FABP6HTR3EHTR3BHTR3ABACE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008075109-A1 SUBSTITUTED PIPERIDINES HAVING PROTEIN KINASE INHIBITING ACTIVITY ASTEX THERAPEUTICS LIMITED (GB) 2008-06-26 WO disclosed
EP-1620413-A2 COMPOUNDS, COMPOSITIONS, AND METHODS Cytokinetics, Inc. (US) 2006-02-01 EP disclosed
WO-2004098494-A2 COMPOUNDS, COMPOSITIONS, AND METHODS CYTOKINETICS, INC. (US) 2004-11-18 WO disclosed